Radiotherapy is one of the most important variables in breast reconstruction. It is often essential for cancer control, but it changes the tissue in ways that make reconstruction more demanding. This article explains the interaction in general terms. It is educational information, not medical advice.

What radiotherapy does to tissue

Radiotherapy targets cancer cells but also affects healthy tissue in the field, reducing its blood supply and elasticity and increasing fibrosis over time. An irradiated chest wall heals differently and is more prone to complications, which is why it weighs so heavily on reconstructive planning.

The timing dilemma

When radiotherapy is planned, teams must decide whether to reconstruct before, during a staged process, or after it — the crux of immediate vs. delayed reconstruction. Irradiating a completed implant reconstruction carries risks; reconstructing into an already-irradiated field carries different ones. There is no single right answer.

Why tissue quality and integration matter more

In a compromised field, everything that supports healing counts. Well-vascularised coverage, careful technique, and materials that encourage revascularisation rather than sitting inert become more important. Fat grafting is sometimes used to improve the quality of irradiated soft tissue over time.

Setting expectations

Honest discussion of the higher complication risk in irradiated reconstruction is part of good care, and is reflected in the wider complication literature. Autologous (flap) reconstruction is sometimes favoured in heavily irradiated fields.

The bottom line

Radiotherapy is frequently necessary but reshapes the reconstructive problem by reducing tissue quality and healing capacity. It strongly influences timing, technique and material choice, and calls for individualised planning within the oncologic pathway.

This article is general educational information, not medical advice. Radiotherapy and reconstruction decisions should be made with your oncology and surgical teams.